The Amniotic Products market is estimated to grow at a CAGR of 8.6% over the forecast period, from USD 0.9 billion in 2021 to USD 1.3 billion in 2027. (2022 - 2027).
The rising frequency of burn injuries, awareness initiatives for wound care treatment and management, rising venture capital investments and government financing, rising number of traumatic wounds, rising number of amniotic membrane transplantations, and rising number of ophthalmology, aesthetic, and orthopedic operations all contribute to the market's growth. Emerging economies, the passage of the 21st-century cures act, and rising demand for stem cell research and regenerative medicine are likely to provide the industry with significant potential possibilities. The challenges and limitations associated with the use of amniote membrane, on the other hand, may hinder market expansion to some extent. The market for amniotic goods is divided into four categories: type, application, end user, and geography.
The report aspects discussed the profile of the top manufacturers of the global Amniotic Products market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Amniotic Products Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
Feb 24, 2020: Integra LifeSciences Launches AmnioExcel® Plus Placental Allograft Membrane--
Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, today announced the launch of AmnioExcel® Plus Placental Allograft Membrane, its latest wound care offering to support soft tissue repair. AmnioExcel Plus is a next generation, thicker, tri-layer, non-side specific allograft consisting of amnion-chorion-amnion layers that aids in creating an environment to help close complex wounds. The proprietary DryFlex® processing technology preserves the inherent growth factors, cytokines and extracellular matrix (ECM) found in native placental tissue.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
By End-User, it is segmented into
North America is predicted to have a considerable market share because to an ageing population, acceptance of sophisticated technologies, expanding population knowledge of alternative technologies, rising healthcare expenditure, and the presence of well-established healthcare infrastructure. The widespread usage of amniotic membranes for eye surface problems has led to their incorporation into ocular procedures. As a result, the growing number of ophthalmic surgeries conducted in the United States as a result of the ageing population is propelling the overall market's expansion to a great extent.
The Amniotic Products Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Amniotic Products Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 8.6% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By End-User |
|
By Companies | MiMedx (US), Smith & Nephew (UK), Organogenesis (US), Integra LifeSciences Corporation (US), Stryker Corporation (US), Wright Medical (Netherlands), Applied Biologics (US), Celularity (US), Katena Products (US), Lucina BioSciences (US), Next Biosciences (South Africa), Skye Biologics (US), Surgenex (US), TissueTech (US), Ventris Medical (US), StimLabs (US), VIVEX Biologics (US), LifeCell International (India), NuVision Biotherapies (England), Genesis Biologics (US) |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 128 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Amniotic Products Market?
The Amniotic Products Market is growing at a CAGR of 8.6% over the next 5 years.
Who are the key players in Amniotic Products Market?
MiMedx (US), Smith & Nephew (UK), Organogenesis (US), Integra LifeSciences Corporation (US), Stryker Corporation (US), Wright Medical (Netherlands), Applied Biologics (US), Celularity (US), Katena Products (US), Lucina BioSciences (US), Next Biosciences (South Africa), Skye Biologics (US), Surgenex (US), TissueTech (US), Ventris Medical (US), StimLabs (US), VIVEX Biologics (US), LifeCell International (India), NuVision Biotherapies (England), Genesis Biologics (US)
What are the significant types of Amniotic Products Market?
Cryopreserved Membranes, Dehydrated Membranes, Suspensions
What are the major end-use applications of Amniotic Products Market?
Wound Care, Orthopedics, Ophthalmology, Others
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.